{
    "summary": "This bill, introduced in the House of Representatives, aims to nullify the Food and Drug Administration's (FDA) January 2023 modifications to the risk evaluation and mitigation strategy (REMS) for the abortion pill mifepristone. It prohibits the Secretary of Health and Human Services from establishing, implementing, or enforcing any substantially similar provisions regarding mifepristone's REMS.",
    "tags": [
        "Healthcare",
        "Women's rights",
        "Federal agency action",
        "Abortion"
    ],
    "category": "Healthcare & Public Health"
}